NanoString Technologies reported after the close of the market on Tuesday that its total revenues declined 28 year over year as collaboration revenues shrank more than threefold.

For the three months ended June 30, total revenues came in at $25 million, down from $34.6 million a year ago when revenues were influenced by significant deferred influx from pharma collaborations.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.